News|Articles|January 28, 2026
Enhanced Paveway™ PLUS Selects Expression Organisms Based on Titer Plus Quality
Author(s)FUJIFILM Biotechnologies
Discover the future of microbial expression with a platform that optimizes strain selection, expression systems, and purification methods, providing actionable insights in just eleven weeks.
Related Content
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup—June 5, 2026
2
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
3
EMA Collaborates with African Regulators on Ebola Treatments
4
Renewing Prosaic Generics for Cancer Treatment
5